Clinical Trial Update: GM1 Prophylaxis for WBRT Related Cognitive Dysfunction [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating GM1 ganglioside prophylaxis to prevent whole-brain radiotherapy-related cognitive dysfunction in patients with brain metastases was t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Cognitive Impairment

Drugs mentioned

• GM1 ganglioside (GM1 ganglioside)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Brain Metastases, Radiotherapy Side Effect | Phase 3 | Status: TERMINATED